do glp 1 affect kidney function Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Glucagon-like peptide 1(GLP-1) receptor agonists

[DOI] [PMC free article] [PubMed] [Google Scholar] 125.You X, Yang Q, Yan K, Wang SR, Huang RR, Wang SQ, Gao CY, Li L, Lian ZX

July 29, 2021

According to a KFF poll, 62% of adults taking GLP-1 drugs reported using them to manage a chronic condition such as diabetes or heart disease, while about four in 10 said they were prescribed GLP-1s primarily to lose weight

Understanding these metabolic mechanisms may pave the way for more effective and personalized treatment strategies for IPF

2 Obesitas is een zogenaamde poortziekte', geassocieerd met meer dan 200 complicaties en comorbiditeiten, waaronder type 2-diabetes (T2DM), metabole disfunctie geassocieerde steatotische leverziekte (MASLD), hart- en vaatziekten, mechanische complicaties (waaronder artrose en slaapapneusyndroom (OSA)), 13 vormen van kanker en (psycho)sociale problemen

Copper Tripeptide-1 leads